Citadel Advisors
SWAV

Citadel Advisors’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Citadel Advisors’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-86,500
Closed -$28.2M – 15780
2024
Q1 		$28.2M Sell
86,500
-13,800
-14% -$3.39M 0.01% 1726
2023
Q4 		$19.1M Buy
100,300
+34,600
+53% +$6.54M ﹤0.01% 2066
2023
Q3 		$13.1M Buy
65,700
+29,200
+80% +$6.91M ﹤0.01% 2350
2023
Q2 		$10.4M Buy
36,500
+10,000
+38% +$2.78M ﹤0.01% 2625
2023
Q1 		$5.75M Sell
26,500
-6,000
-18% -$1.17M ﹤0.01% 3573
2022
Q4 		$6.68M Sell
32,500
-29,500
-48% -$7.46M ﹤0.01% 3410
2022
Q3 		$17.2M Buy
62,000
+18,500
+43% +$4.7M ﹤0.01% 2040
2022
Q2 		$8.32M Buy
43,500
+5,700
+15% +$1.01M ﹤0.01% 2929
2022
Q1 		$7.84M Buy
37,800
+11,900
+46% +$1.96M ﹤0.01% 3353
2021
Q4 		$4.62M Sell
25,900
-32,500
-56% -$6.41M ﹤0.01% 4453
2021
Q3 		$12M Buy
58,400
+20,900
+56% +$4.1M ﹤0.01% 2750
2021
Q2 		$7.12M Buy
37,500
+15,100
+67% +$2.47M ﹤0.01% 3712
2021
Q1 		$2.92M Sell
22,400
-3,000
-12% -$360K ﹤0.01% 5515
2020
Q4 		$2.63M Buy
25,400
+10,000
+65% +$866K ﹤0.01% 4799
2020
Q3 		$1.17M Buy
15,400
+10,200
+196% +$578K ﹤0.01% 5751
2020
Q2 		$246K Sell
5,200
-1,900
-27% -$78.3K ﹤0.01% 8237
2020
Q1 		$236K Buy
7,100
+2,000
+39% +$79.4K ﹤0.01% 7731
2019
Q4 		$224K Buy
+5,100
New +$188K ﹤0.01% 8024

Other funds holding SWAV

SA
Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return
UWS
Unique Wealth Strategies Burr Ridge, Illinois $275M AUM 29.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Citadel Advisors's SWAV Position: Q2 2024 in Review

Citadel Advisors sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 495,358 shares — an estimated $161M sold.

Citadel Advisors first reported a position in SWAV in Q1 2019 and held it in 20 quarters. The position peaked at $170M in Q4 2023. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Citadel Advisors reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Citadel Advisors sold 495,358 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $161M.
  • Citadel Advisors first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2019 and held it in 20 quarters.
  • Citadel Advisors's Shockwave Medical, Inc. Common Stock position peaked at $170M in Q4 2023.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.